Literature DB >> 31553151

BHQ-Cyanine-Based "Off-On" Long-Circulating Assembly as a Ferroptosis Amplifier for Cancer Treatment: A Lipid-Peroxidation Burst Device.

Mangmang Sang1, Renjie Luo1, Yidan Bai1, Jun Dou1, Zhongtao Zhang2, Fulei Liu, Feng Feng2,3, Wenyuan Liu1,4.   

Abstract

Ferroptosis is an iron-dependent cell death caused by accumulation of lipid peroxidation (LPO), which is a new strategy for cancer treatment. Th current ferroptosis therapy nanodevices have low efficiency and side effects generally. Hence, we developed a Black Hole Quencher (BHQ)-based fluorescence "off-on" nanophotosensitizer complex assembly (CSO-BHQ-IR780-Hex/MIONPs/Sor). CSO-connected BHQ-IR780-Hex and -loaded magnetic iron oxide nanoparticles (MIONPs) and sorafenib (Sor) formed a very concise functionalized delivery system. CSO-BHQ-IR780-Hex disassembled by GSH attack and released IR780-Hex, MIONPs, and sorafenib. IR780-Hex anchored to the mitochondrial membrane, which would contribute to amplifying the efficiency of the photosensitizer. When NIR irradiation was given to CSO-BHQ-IR780-Hex/MIONPs/Sor-treated cells, iron supply increased, the xCT/GSH/GPX-4 system was triggered, and a lot of LPO burst. A malondialdehyde test showed that LPO in complex assembly-treated cells was explosive and increased about 18-fold compared to the control. The accumulation process of particles was monitored by an IR780-Hex photosensitizer, which showed an excellent tumor target ability by magnetic of nanodevice in vivo. Interestingly, the half-life of sorafenib in a nanodevice was increased about 26-fold compared to the control group. Importantly, the complex assembly effectively inhibits tumor growth in the breast tumor mouse model. This work would provide ideas in designing nanomedicines for the ferroptosis treatment of cancer.

Entities:  

Keywords:  Black Hole Quencher; breast cancer; ferroptosis; lipid peroxidation; nanophotosensitizer

Mesh:

Substances:

Year:  2019        PMID: 31553151     DOI: 10.1021/acsami.9b12469

Source DB:  PubMed          Journal:  ACS Appl Mater Interfaces        ISSN: 1944-8244            Impact factor:   9.229


  11 in total

1.  Disulfiram, a Ferroptosis Inducer, Triggers Lysosomal Membrane Permeabilization by Up-Regulating ROS in Glioblastoma.

Authors:  Chen Qiu; Xin Zhang; Bin Huang; Shuai Wang; Wenjing Zhou; Chao Li; Xingang Li; Jian Wang; Ning Yang
Journal:  Onco Targets Ther       Date:  2020-10-20       Impact factor: 4.147

2.  Development and Verification of a Prognostic Ferroptosis-Related Gene Model in Triple-Negative Breast Cancer.

Authors:  Song Wu; Ruilin Pan; Jibu Lu; Xiaoling Wu; Jingdong Xie; Hailin Tang; Xing Li
Journal:  Front Oncol       Date:  2022-06-02       Impact factor: 5.738

3.  Co-Administration of iRGD with Sorafenib-Loaded Iron-Based Metal-Organic Framework as a Targeted Ferroptosis Agent for Liver Cancer Therapy.

Authors:  Xianchuang Liu; Xinyang Zhu; Xun Qi; Xianwei Meng; Ke Xu
Journal:  Int J Nanomedicine       Date:  2021-02-11

Review 4.  Epigenetic Regulation and Nonepigenetic Mechanisms of Ferroptosis Drive Emerging Nanotherapeutics in Tumor.

Authors:  Yue Cheng; Yao Xie; Yan Chen; Xiaojing Liu
Journal:  Oxid Med Cell Longev       Date:  2021-01-29       Impact factor: 6.543

5.  Hypoxia responsive nano-drug delivery system based on angelica polysaccharide for liver cancer therapy.

Authors:  Xue Liu; Zhenfeng Wu; Chunjing Guo; Huimin Guo; Yanguo Su; Qiang Chen; Changgang Sun; Qingming Liu; Daquan Chen; Hongjie Mu
Journal:  Drug Deliv       Date:  2022-12       Impact factor: 6.419

Review 6.  Multifunctional Nanomaterials for Ferroptotic Cancer Therapy.

Authors:  Zhiyuan Shi; Jianzhong Zheng; Wenbin Tang; Yang Bai; Lei Zhang; Zuodong Xuan; Huimin Sun; Chen Shao
Journal:  Front Chem       Date:  2022-03-24       Impact factor: 5.221

Review 7.  Targeting Ferroptosis in Colorectal Cancer.

Authors:  Xiaojie Liang; Zhihuan You; Xinhao Chen; Jun Li
Journal:  Metabolites       Date:  2022-08-12

8.  Human umbilical cord mesenchymal stem cells ameliorate erectile dysfunction in rats with diabetes mellitus through the attenuation of ferroptosis.

Authors:  Huan Feng; Qi Liu; Zhiyao Deng; Hao Li; Huajie Zhang; Jingyu Song; Xiaming Liu; Jihong Liu; Bo Wen; Tao Wang
Journal:  Stem Cell Res Ther       Date:  2022-09-05       Impact factor: 8.079

Review 9.  System Xc -/GSH/GPX4 axis: An important antioxidant system for the ferroptosis in drug-resistant solid tumor therapy.

Authors:  Feng-Jiao Li; Hui-Zhi Long; Zi-Wei Zhou; Hong-Yu Luo; Shuo-Guo Xu; Li-Chen Gao
Journal:  Front Pharmacol       Date:  2022-08-29       Impact factor: 5.988

Review 10.  Recent advances of sorafenib nanoformulations for cancer therapy: Smart nanosystem and combination therapy.

Authors:  Fangmin Chen; Yifan Fang; Xiang Chen; Rui Deng; Yongjie Zhang; Jingwei Shao
Journal:  Asian J Pharm Sci       Date:  2020-08-21       Impact factor: 6.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.